# Daniela Couto

> Daniela Couto is a seed investor at BioGeneration Ventures backing Biotechnology and Medical. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BioGeneration Ventures](https://shizune.co/investors/profile/biogeneration-ventures)
- Location: Amsterdam, The Netherlands
- Total investments: 3
- Last investment: Jan 2025
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/danielacouto/
- Facebook: https://www.facebook.com/daniela.s.couto

Daniela Couto is a seed investor at BioGeneration Ventures in Amsterdam focused on Biotechnology and Medical. Daniela Santos Couto is based out of Naarden, Noord-Holland and is the General Partner of BioGeneration Ventures. Daniela previously worked at CatalYm GmbH as a Board Member. Daniela Santos Couto attended the Instituto Superior Técnico. Daniela Santos Couto has received Summa cum Laude award.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Medical | 1 | 33% |
| Therapeutics | 1 | 33% |
| Product Research | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Series A | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Switzerland | 1 | 33% |
| The Netherlands | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Rhygaze | Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness. | $86M | Series A | Jan 10, 2025 |  |
| Rhygaze | Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness. | $11.3M | Seed | Jul 17, 2024 |  |
| Tessellate BIO | Tessellate BIO is a biotechnology business in the preclinical stage that focuses on advanced Synthetic Lethality techniques. It develops precision oncology methods to treat tumors with significant unmet medical needs. | $8.5M | Seed | Oct 17, 2023 |  |

3 of 3 investments shown.

## Co-investors
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 2 deals together
- [Novartis Venture Fund](https://shizune.co/investors/profile/novartis-venture-fund) — VC Fund, 2 deals together
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 1 deal together
- [Forbion Capital Partners](https://shizune.co/investors/profile/forbion-capital-partners) — VC Fund, 1 deal together
- [F-Prime](https://shizune.co/investors/profile/f-prime-capital-partners) — VC Fund, 1 deal together

## About BioGeneration Ventures

VC Fund · Naarden, The Netherlands

BioGeneration Ventures is investing in the next generation of Life Sciences companies in the Netherlands. BioGeneration Ventures invests in Dutch start-up and early stage life sciences companies. The BioGeneration Ventures team is specialized in the evaluation and management of early stage companies. Their involvement goes beyond thefinancial investment. They work closely with scientists, academic institutions, entrepreneurs and industry experts to accelerate the development and to optimize the commercial potential of their portfolio company's technologies. BioGeneration Ventures began operating in 2006 and the fund is backed by the Netherlands Genomics Initiative (NGI) and the Netherlands Organisation for Scientific Research (NWO) in combination with the holding company of Leiden University and ABN-AMRO Capital as lead private investors.

5 contacts available at BioGeneration Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Daniela Couto | General Partner | https://shizune.co/investors/profile/daniela-couto |
| Edward van Wezel | Founder and Managing Partner | https://shizune.co/investors/profile/edward-van-wezel |
| Joost Holthuis | Venture Partner | https://shizune.co/investors/profile/joost-holthuis |
| Oskar Slotboom | Managing Partner | https://shizune.co/investors/profile/oskar-slotboom |
| Elena Ritsou | Venture Partner | https://shizune.co/investors/profile/elena-ritsou |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Daniela Couto invest in?

Daniela Couto invests primarily in Biotechnology, Medical and Therapeutics startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Daniela Couto last invest?

The most recent investment recorded for Daniela Couto closed in Jan 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co